Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07638982 · ClinicalTrials.gov registry record · Phase 1
Axatilimab + CAR-T for High-Risk Lymphoma
A Phase 1 study, sponsored by Northside Hospital.
- Not yet
- Registry status
- Phase 1
- Development phase
- 29
- Enrollment target
NCT07638982: Clinical Trial Phase 1 study, sponsored by Northside Hospital.
NCT07638982 is a Phase 1 study that has not yet begun recruiting, run by Northside Hospital. The registered enrollment target is 29 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (52% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07638982, a Phase 1 study, has not yet begun recruiting, sponsored by Northside Hospital.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 29 participants
- Enrollment target
Study Summary
Axatilimab + CAR-T in High-Risk Lymphoma
Primary Outcome
Determine the recommended Phase 2 dose (RP2D) of axatilimab in combination with CAR T cell therapy by following a fast-track dose escalation design and assessing adverse events, using the CTCAE Version 6, related to axatilimab
Interventions
- DRUG Axatilimab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2026-10-31 |
| Est. Completion | 2029-12-31 |
| Phase | Phase 1 |
What is known before NCT07638982 opens enrollment
NCT07638982 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (52% lower).
The record links to 0 conditions, and to 1 intervention - of which Axatilimab is the first listed.
NCT07638982 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07638982 about?
NCT07638982 is a clinical study titled "Axatilimab + CAR-T for High-Risk Lymphoma". Axatilimab + CAR-T in High-Risk Lymphoma
What is the current status of trial NCT07638982?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 29 participants. The study started on 2026-10-31. Estimated completion is 2029-12-31.
What interventions are being tested in trial NCT07638982?
The interventions under investigation include: Axatilimab (DRUG).
Who is sponsoring clinical trial NCT07638982?
This trial is sponsored by Northside Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07638982's enrollment target sits among peer trials
29 1440th of 2000 higher than 554 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI